关注
Jana Ruda-Kucerova
Jana Ruda-Kucerova
在 med.muni.cz 的电子邮件经过验证
标题
引用次数
引用次数
年份
Health safety issues of synthetic food colorants
P Amchova, H Kotolova, J Ruda-Kucerova
Regulatory toxicology and pharmacology 73 (3), 914-922, 2015
6302015
Anticancer activity of artemisinin and its derivatives
S Slezáková, J Ruda-Kucerova
Anticancer research 37 (11), 5995-6003, 2017
1782017
Principles of diffusion kurtosis imaging and its role in early diagnosis of neurodegenerative disorders
A Arab, A Wojna-Pelczar, A Khairnar, N Szabó, J Ruda-Kucerova
Brain research bulletin 139, 91-98, 2018
942018
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia
T Stark, J Ruda-Kucerova, FA Iannotti, C D'Addario, R Di Marco, V Pekarik, ...
Neuropharmacology 146, 212-221, 2019
772019
HDAC1 and HDAC3 underlie dynamic H3K9 acetylation during embryonic neurogenesis and in schizophrenia‐like animals
J Večeřa, E Bártová, J Krejčí, S Legartová, D Komůrková, ...
Journal of cellular physiology 233 (1), 530-548, 2018
762018
Sex differences in the reinstatement of methamphetamine seeking after forced abstinence in Sprague-Dawley rats
J Ruda-Kucerova, P Amchova, Z Babinska, L Dusek, V Micale, A Sulcova
Frontiers in psychiatry 6, 91, 2015
742015
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol …
M Di Bartolomeo, T Stark, OM Maurel, FA Iannotti, M Kuchar, ...
Pharmacological Research 164, 105357, 2021
532021
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment
T Stark, M Di Bartolomeo, R Di Marco, E Drazanova, CBM Platania, ...
Biochemical Pharmacology 177, 114004, 2020
512020
Different effects of prenatal MAM vs. perinatal THC exposure on regional cerebral blood perfusion detected by Arterial Spin Labelling MRI in rats
E Drazanova, J Ruda-Kucerova, L Kratka, T Stark, M Kuchar, M Maryska, ...
Scientific Reports 9 (1), 6062, 2019
372019
Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats
J Ruda-Kucerova, Z Babinska, P Amchova, T Stark, F Drago, A Sulcova, ...
The World Journal of Biological Psychiatry 18 (2), 129-142, 2017
372017
Early and progressive microstructural brain changes in mice overexpressing human α-Synuclein detected by diffusion kurtosis imaging
A Khairnar, J Ruda-Kucerova, N Szabó, E Drazanova, A Arab, ...
Brain, behavior, and immunity 61, 197-208, 2017
342017
Low vs. high alcohol: central benefits vs. detriments
Y Tizabi, B Getachew, CL Ferguson, AB Csoka, KM Thompson, ...
Neurotoxicity Research 34, 860-869, 2018
332018
Olanzapine-depot administration induces time-dependent changes in adipose tissue endocrine function in rats
K Horska, J Ruda-Kucerova, Z Babinska, M Karpisek, R Demlova, ...
Psychoneuroendocrinology 73, 177-185, 2016
322016
Reward related neurotransmitter changes in a model of depression: an in vivo microdialysis study
J Ruda-Kucerova, P Amchova, T Havlickova, P Jerabek, Z Babinska, ...
The World Journal of Biological Psychiatry 16 (7), 521-535, 2015
322015
Differential characteristics of ketamine self-administration in the olfactory bulbectomy model of depression in male rats.
Z Babinska, J Ruda-Kucerova
Experimental and clinical psychopharmacology 25 (2), 84, 2017
262017
Poly (I: C) model of schizophrenia in rats induces sex-dependent functional brain changes detected by MRI that are not reversed by aripiprazole treatment
E Drazanova, J Ruda-Kucerova, L Kratka, K Horska, R Demlova, ...
Brain research bulletin 137, 146-155, 2018
252018
Both ketamine and NBQX attenuate alcohol drinking in male Wistar rats
J Ruda-Kucerova, Z Babinska, M Luptak, B Getachew, Y Tizabi
Neuroscience letters 666, 175-180, 2018
252018
Suppression of methamphetamine self-administration by ketamine pre-treatment is absent in the methylazoxymethanol (MAM) rat model of schizophrenia
J Ruda-Kucerova, Z Babinska, T Stark, V Micale
Neurotoxicity research 32, 121-133, 2017
202017
Late‐stage α‐synuclein accumulation in TNWT‐61 mouse model of Parkinson's disease detected by diffusion kurtosis imaging
A Khairnar, J Ruda‐Kucerova, E Drazanova, N Szabó, P Latta, A Arab, ...
Journal of neurochemistry 136 (6), 1259-1269, 2016
192016
Diffusion kurtosis imaging detects microstructural alterations in brain of α-synuclein overexpressing transgenic mouse model of Parkinson’s disease: a pilot study
A Khairnar, P Latta, E Drazanova, J Ruda-Kucerova, N Szabó, A Arab, ...
Neurotoxicity research 28, 281-289, 2015
192015
系统目前无法执行此操作,请稍后再试。
文章 1–20